spinal muscular atrophy with congenital bone fractures 2

Rare Disease

MONDO:0014807

Also known as:

ASCC1 prenatal-onset spinal muscular atrophy with congenital bone fracturesSMABF2prenatal-onset spinal muscular atrophy with congenital bone fractures caused by mutation in ASCC1

Any prenatal-onset spinal muscular atrophy with congenital bone fractures in which the cause of the disease is a mutation in the ASCC1 gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in spinal muscular atrophy with congenital bone fractures 2

3 approved

Organizations with approved therapies for this disease

Novartis Gene Therapies

Other

Approved

Biogen Inc.

Other

Approved

Genentech, Inc.

Other

Approved

View all companies active in spinal muscular atrophy with congenital bone fractures 2

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases